What’s it about?
Repetitive negative thinking, such as worrying (silently talking to ourselves about possible catastrophic outcomes) and ruminating (thinking about personal failings or why things have gone wrong in the past), is something we all do from time to time.
Worry and rumination play an important role in preventing people from recovering from common but very disabling mental health conditions. Uncontrollable worry is the driving feature of Generalised Anxiety Disorder and rumination is very common in Depression.
Both these thinking styles are common in people with Parkinson’s. Understanding how to reduce these negative thought patterns by targeting underlying processes will lead to better quality of life.
What is the objective?
The aim of the study is to develop new treatments for repetitive negative thinking patterns related to anxiety, suitable for people with Parkinson’s.
Where is it?
At home on a PC or laptop computer, or one elsewhere that you can use privately. You must be able to use the mouse and keyboard unassisted. You will need to speak to a researcher on the telephone, or have your partner or carer speak for you.
How long does it take?
Most of the Study is accomplished over a three-week period. There will be two assessments using the PC or laptop at the start and end of the period, each of which will take around 50 minutes to complete. In between the assessments there will ten computer assignments to complete, no more than one per day.
There will be two follow-up assessments, one month and three months later, each lasting around 30 minutes. The Participant Information Sheet mentions headphones; PC/Laptop speakers will be adequate for most people.
Who is eligible?
You must have a diagnosis of idiopathic Parkinson’s and often worry about different things. There is a screening interview by telephone after you have enrolled.
How do I enrol?
Go to the PD-Lens Registration page.
For more information read the Participant Information Sheet.
Who is conducting the Study?
The Study is being conducted by the Cognition in Emotional Disorders and Resilience (CEDAR) group at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London. The study is funded by Parkinson’s UK.